Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,843
archived clinical trials in
Prostate Cancer

Lycopene in Treating Patients With Metastatic Prostate Cancer
A Phase II Trial Of Lycopene For Patients With Asymptomatic Androgen-Independent Metastatic Prostate Cancer With PSA Elevation
Status: Enrolling
Updated:  7/12/2016
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Lycopene in Treating Patients With Metastatic Prostate Cancer
A Phase II Trial Of Lycopene For Patients With Asymptomatic Androgen-Independent Metastatic Prostate Cancer With PSA Elevation
Status: Enrolling
Updated: 7/12/2016
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence
A Phase III Randomized Prospective Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence
Status: Enrolling
Updated:  7/13/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence
A Phase III Randomized Prospective Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence
Status: Enrolling
Updated: 7/13/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
A Phase I Clinical Trial of mTOR Inhibition With Rapamycin for Enhancing Intranodal Dendritic Cell Vaccine Induced Anti-tumor Immunity in Patients With NY-ESO-1 Expressing Solid Tumors
Status: Enrolling
Updated:  7/25/2016
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
A Phase I Clinical Trial of mTOR Inhibition With Rapamycin for Enhancing Intranodal Dendritic Cell Vaccine Induced Anti-tumor Immunity in Patients With NY-ESO-1 Expressing Solid Tumors
Status: Enrolling
Updated: 7/25/2016
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Antibiotic Prophylaxis for Urinary Catheter Removal After Radical Prostatectomy
Antibiotic Prophylaxis for Urinary Catheter Removal After Radical Prostatectomy
Status: Enrolling
Updated:  7/25/2016
Univ of Rochester Medical Center
mi
from
Rochester, NY
Antibiotic Prophylaxis for Urinary Catheter Removal After Radical Prostatectomy
Antibiotic Prophylaxis for Urinary Catheter Removal After Radical Prostatectomy
Status: Enrolling
Updated: 7/25/2016
Univ of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
For Cause Prostate Biopsy in REDUCE Population Trial
Determining the Likelihood of Prostate Cancer Detection in Men Taking Dutasteride When Biopsy is Performed 'for Cause'.
Status: Enrolling
Updated:  8/9/2016
Cleveland Clinic
mi
from
Cleveland, OH
For Cause Prostate Biopsy in REDUCE Population Trial
Determining the Likelihood of Prostate Cancer Detection in Men Taking Dutasteride When Biopsy is Performed 'for Cause'.
Status: Enrolling
Updated: 8/9/2016
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Neoadjuvant Ipilimumab in Prostate Cancer
A Neoadjuvant Phase IIa Study of Ipilimumab {Formerly Known as MDX-010 (BMS-734016)} Plus Hormone Ablation in Men With Prostate Cancer Followed by Radical Prostatectomy.
Status: Enrolling
Updated:  8/18/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Neoadjuvant Ipilimumab in Prostate Cancer
A Neoadjuvant Phase IIa Study of Ipilimumab {Formerly Known as MDX-010 (BMS-734016)} Plus Hormone Ablation in Men With Prostate Cancer Followed by Radical Prostatectomy.
Status: Enrolling
Updated: 8/18/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Magnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate Cancer
Imaging Prostatic Lipids to Distinguish Aggressive Prostate Cancer
Status: Enrolling
Updated:  11/28/2016
Portland VA Medical Center
mi
from
Portland, OR
Magnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate Cancer
Imaging Prostatic Lipids to Distinguish Aggressive Prostate Cancer
Status: Enrolling
Updated: 11/28/2016
Portland VA Medical Center
mi
from
Portland, OR
Click here to add this to my saved trials
Magnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate Cancer
Imaging Prostatic Lipids to Distinguish Aggressive Prostate Cancer
Status: Enrolling
Updated:  11/28/2016
Oregon Health & Science University Advanced Imaging Research Center
mi
from
Portland, OR
Magnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate Cancer
Imaging Prostatic Lipids to Distinguish Aggressive Prostate Cancer
Status: Enrolling
Updated: 11/28/2016
Oregon Health & Science University Advanced Imaging Research Center
mi
from
Portland, OR
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Anchorage, AK
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Anchorage, AK
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Phoenix, AZ
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Little Rock, AR
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Anaheim, CA
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Anaheim, CA
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
La Mesa, CA
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
La Mesa, CA
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Laguna Hills, CA
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Laguna Hills, CA
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Los Angeles, CA
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Poway, CA
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Poway, CA
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
San Bernardino, CA
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
San Bernardino, CA
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
San Diego, CA
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Tarzana, CA
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Tarzana, CA
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Torrance, CA
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Torrance, CA
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Denver, CO
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Denver, CO
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Englewood, CO
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Englewood, CO
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Longmont, CO
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Longmont, CO
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
New Britain, CT
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
New Britain, CT
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Washington,
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Washington,
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Longwood, FL
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Longwood, FL
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Orlando, FL
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Orlando, FL
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Panellas Park, FL
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Panellas Park, FL
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Pinecrest, FL
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Pinecrest, FL
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Coeur d'Alene, ID
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Coeur d'Alene, ID
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Galesburg, IL
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Galesburg, IL
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Fort Wayne, IN
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Greenwood, IN
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Greenwood, IN
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Jeffersonville, IN
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Jeffersonville, IN
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Overland Park, KA
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Overland Park, KA
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Wichita, KA
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Wichita, KA
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Annapolis, MD
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Annapolis, MD
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Towson, MD
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Towson, MD
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Boston, MA
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Boston, MA
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Watertown, MA
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Watertown, MA
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Royal Oak, MI
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Royal Oak, MI
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
St. Joseph, MI
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
St. Joseph, MI
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Chaska, MN
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Chaska, MN
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Sartell, MN
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Sartell, MN
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Kansas City, MO
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Kansas City, MO
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Springfield, MO
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Springfield, MO
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
St. Louis, MO
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
St. Louis, MO
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Omaha, NE
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Omaha, NE
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
West Orange, NJ
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
West Orange, NJ
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Albany, NY
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Albany, NY
Click here to add this to my saved trials